BLACKFORD GARY 4

Accession 0001235802-20-000124

CIK 0001492658other

Filed

Nov 12, 7:00 PM ET

Accepted

Nov 13, 3:03 PM ET

Size

25.4 KB

Accession

0001235802-20-000124

Form 4

Period: 2020-11-11

Director

Transactions

Disposition from Tender
Ordinary Shares, par value EUR 0.03 per share
2020-11-11$30.75/sh−75,782$2,330,297→ 0 total
Disposition to Issuer
Stock Option (right to buy)
2020-11-11−10,275→ 0 total
Exercise: $27.86Exp: 2027-07-25→ Ordinary Shares (10,275 underlying)
Disposition to Issuer
Stock Option (right to buy)
2020-11-11−10,309→ 0 total
Exercise: $23.93Exp: 2023-05-14→ Ordinary Shares (10,309 underlying)
Disposition to Issuer
Stock Option (right to buy)
2020-11-11−11,018→ 0 total
Exercise: $20.62Exp: 2025-10-13→ Ordinary Shares (11,018 underlying)
Disposition to Issuer
Stock Option (right to buy)
2020-11-11−9,907→ 0 total
Exercise: $24.49Exp: 2028-07-24→ Ordinary Shares (9,907 underlying)
Disposition to Issuer
Stock Option (right to buy)
2020-11-11−11,765→ 0 total
Exercise: $21.24Exp: 2026-07-19→ Ordinary Shares (11,765 underlying)
Disposition to Issuer
Stock Option (right to buy)
2020-11-11−10,309→ 0 total
Exercise: $29.06Exp: 2024-05-13→ Ordinary Shares (10,309 underlying)
Disposition to Issuer
Stock Option (right to buy)
2020-11-11−10,309→ 0 total
Exercise: $20.75Exp: 2022-05-09→ Ordinary Shares (10,309 underlying)
Disposition to Issuer
Stock Option (right to buy)
2020-11-11−7,731→ 0 total
Exercise: $15.04Exp: 2021-05-11→ Ordinary Shares (7,731 underlying)
Disposition to Issuer
Stock Option (right to buy)
2020-11-11−11,691→ 0 total
Exercise: $27.84Exp: 2029-07-26→ Ordinary Shares (11,691 underlying)

Footnotes (2)

[F1]On November 4, 2019, Wright Medical Group N.V. (the Issuer) entered into a purchase agreement (the Purchase Agreement) with Stryker Corporation and its subsidiary, Stryker B.V. (the Purchaser). Pursuant to the terms of the Purchase Agreement, the Purchaser commenced a tender offer for all the outstanding ordinary shares, par value EUR 0.03 per share (Shares), of the Issuer (the Offer), and on November 11, 2020 (the Acceptance Time), the Purchaser accepted all of the Shares that were validly tendered and not properly withdrawn pursuant to the Offer, including 75,782 Shares tendered by the reporting person, in exchange for a cash payment equal to $30.75 per Share, without interest and less applicable withholding taxes (the Offer Consideration), which Offer Consideration will be paid as promptly as practicable following the Closing (as defined in the Purchase Agreement).
[F2]Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a Wright Stock Option) that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time and, at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes.

Documents

1 file

Wright Medical Group N.V.

CIK 0001492658

Entity typeother

IncorporatedMN